1 / 101

“Litz” Blitz 2013 Top Articles in Pediatric Hospital Medicine

“Litz” Blitz 2013 Top Articles in Pediatric Hospital Medicine. Benjamin D. Bauer, MD, FAAP June 1st, 2013. A review of recent literature impacting the practice of pediatric medicine. Disclosure Statement. Benjamin D. Bauer : Has no relevant financial relationships to disclose.

kiayada-madden
Télécharger la présentation

“Litz” Blitz 2013 Top Articles in Pediatric Hospital Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “Litz” Blitz 2013Top Articles in Pediatric Hospital Medicine Benjamin D. Bauer, MD, FAAP June 1st, 2013 A review of recent literature impacting the practice of pediatric medicine

  2. Disclosure Statement • Benjamin D. Bauer: • Has no relevant financial relationships to disclose. • Has no conflicts of interest to resolve. • This presentation will not involve discussion of unapproved, off-label, or experimental interventions or medications.

  3. Strategy & Criteria for Article Selection: • Reviewed literature from the past 18 months: • Pediatrics, Hospital Pediatrics, JAMApeds, JAMA, NEJM<, Archives of Pediatrics & Adolescent Med, Journal of Pediatrics, Pediatric Infectious Disease, Journal of Hospital Medicine, Pediatric Emergence Care • Selection based on general interest and potential to impact practice of pediatric hospital medicine • General guidelines of the 3 R’s: • Recent, Relevant and Reputable.

  4. Strategy & Criteria for Article Selection: • Final selection of articles, also considered ‘clinical grouping’ based on areas of interest to pediatric hospitalists • Here are the clinical topics that will be covered in today’s talk: • Febrile Neonate / SBI • Fluid management • Failure to Thrive • Gastroesophageal Reflux • Hyperbilirubinemia • Bronchiolitis • Pneumonia

  5. Disclaimer: • Literature presented was chosen based general interest of the presenter • No claim made regarding whether these are the most well-designed studies on a given topic • The literature discussed should be critically and individually reviewed before change in practice is implemented • Feel free to throw rotten fruit… but kindly wait until the end of the presentation

  6. The Febrile Infant

  7. Background • Serious Bacterial Infection (SBI) evaluation remains a challenge • SBI Rates as high as 10-12% <3mo of age • UTI accounts for majority of SBI • Bacteremia and meningitis are less common • Risk stratification strategies have been developed; remain controversial • Even those suggesting less invasive strategies push for LP prior to starting antibiotics

  8. Background / Study Objective • Rochester Criteria for Febrile Infants: • Infant appears well • Infant has been previously healthy • No evidence of skin, bone, joint or ear infection • Labs: WBC 5K – 15K; Bands < 1,500; < 10 WBCs in U/A; No pus in stool • When ALL criteria met; NPV for SBI is 98.9% • Study Aim: Necessity of performing routine LP in well appearing 30-90 day old febrile infant with U/A suggestive of UTI

  9. Study Methods • Retrospective Study • Tertiary care children’s hospital ED; 200 pt/day • 4 year period; October 2001 – August 2005 • Identified all febrile infants 30-90 days of life: • underwent full sepsis work-up: LP for culture, blood culture, urine culture and urinalysis. • Exclusion Criteria: Premature (<35wk), chronic conditions, pre-culture antibiotics, or localizing infection on presentation

  10. Results: N = 392 30-90 day febrile infants full sepsis evaluation • Highlights: • 392 patients included • 61% male (241/392) • Mean age 56 days • Overall Rates of Infection: • SBI: 60/392 (15.3%) • UTI: 52/392 (13.3%) • Sepsis: 13/392 (3.3%) • Meningitis: 4/392 (1%) • Only 1 patient with both abnormal U/A and Meningitis 1 + Culture 52 patients 2 + Cultures 7 patients 3 + Cultures 1 patient Blood & Urine 5 patients CSF, Blood & Urine 1 patient CSF, Blood & Urine 1 patient Blood, Urine & CSF 1 patient Urine only 46 patients Urine & Blood 5 patients Urine, Blood & CSF 1 Patient CSF & Blood 2 patients Blood only 5 patients Blood & CSF 2 patients CSF only 1 patients

  11. Results • 1 patient with both abnormal U/A and meningitis • 71 day old female: • Urinalysis: LE+, Nitrite+, 4WBCs/HPF • WBC: 2.9 x 109 • Cultures: E. coli (Blood, Urine and CSF) • Clinical: 38.5◦C, irritable, lethargic, mottled • NOT Low Risk by Rochester: Based on signs/sx would have undergone full sepsis work up

  12. Patients with meningitis

  13. Results • Of the 388 infants without meningitis: • 56 (14%) had an abnormal U/A • 51 (13%) had a culture positive UTI • Negative Predictive Value (NPV): • 98.2% NPV • 100% NPV, if Rochester ‘low risk’ criteria are met • Does not change the overall NPV of the Rochester criteria, but does potentially add to discussion regarding risk of meningitis

  14. Study Limitations • May not generalize: Tertiary Care ED vs..outpatient • Small sample size: Decreases power to identify the potential case of meningitis in this population • Retrospective design: Impossible to confirm that all “NON-low risk” infants actually underwent full septic work-up. • Underestimates downstream impact: Does not acknowledge difficulty for those making decisions regarding management, if LP not done at antibiotic initiation.

  15. Clinical Bottom Line • Study confirms findings of others: • Combined UTI and meningitis is uncommon in infants <90 days of age ( 0% – 0.3%) • Routine LPs may not be necessary in infants 30-90 days of life, if otherwise low-risk based on Rochester criteria • If any uncertainty, or patient not well appearing then an LP MUST BE DONE prior to starting antibiotics

  16. In search of the 24 hour discharge…

  17. Background • The management of the febrile infant is evolving • Still common for infants with fever and no clear source to remain in hospital receiving empiric treatment for 48hrs while culture results mature • Some institutions have used available evidence to push the LOS envelope for these patients…

  18. Evidence Based Care Process Model

  19. Study Objectives • To determine if bacterial cultures in young infants would produce results in <36 hours • With enough reliability to allow for discharge of otherwise healthy infants earlier than the standard 48 hour observation period

  20. Methods • Retrospective chart review • Oct 2007 – Feb 2011 (3 yrs 4 months) • All positive culture results (Blood, Urine, CSF) • Drawn on infants 0 – 90 days of age during the evaluation of SBI in ED or as inpatient • Exclusion: Any indwelling lines, shunts, catheters; any cultures drawn while in ICU setting; significant underlying condition; repeat cultures taken from same patient during same stay

  21. Results • 283 patients with positive cultures • 2092 Blood cultures were drawn • 38% (38/101) of blood cultures = true pathogens • Mean time to detection (TTD) 13.3 hours (vs.. 25 hrs) • 2283 Urine cultures were drawn • 58% (111/192) of urine cultures = true pathogens • Mean TTD 21 hours (vs.. 26.7 hrs) • 1159 CSF cultures were drawn • 50% (7/14) of CSF cultures = true pathogens • Mean TTD 28.9 hours (vs.. 57.7 hrs)

  22. Time To Detection of Bacterial Cultures

  23. Bottom Line • This article adds to existing data about management of febrile neonate • Already excellent data to help with risk stratification (Rochester criteria…) • Those infants admitted to the hospital as ‘Low Risk’ have SBI rates in range of 1-3% • In the appropriate clinical and social context • May consider discontinue antibiotics therapy at 36 hours

  24. Fluids Management

  25. Background • Hospital acquired hyponatremia is common • Neurologic morbidity and death have been documented as a result of iatrogenic hyponatremia • Has raised questions regarding 50yr standard of using Holliday-Segar recommendations for calculating parenteral maintenance fluids • Growing evidence emerging that the use of isotonic fluids may decrease risk

  26. Study Objectives • Fully blinded, randomized controlled trial • Determine whether isotonic solution administered as maintenance IV fluids decrease the risk of hyponatremia when compared to hypotonic fluids • Population: euvolemic pediatric patients in the acute post-operative period, with non-emergent reasons for surgery; requiring MIVF for 48hrs

  27. Study Methods • IRB approved, Blinded, RCT • Tertiary care children’s hospital, Canada • Randomly assigned to receive base parenteral maintenance solution (PMS) of either 0.45% saline (hypotonic) or 0.9% saline (isotonic) • Dextrose (D5) present in both • Potassium added according treating MD request • 6mo – 16yrs; euvolemic; within 6hrs of non-emergent surgery; likely to need MIVF >24hrs

  28. Study methods / Outcome measures • Plasma sodium, Urine sodium/potassium and ADH measured every 12 hours • Intervention was started immediately post-op and continued for maximum of 48hrs • Primary Outcome: Hyponatremia; ≤ 134mmol/L • Secondary Outcomes: Severe hyponatremia (≤ 129mmol/L), hypernatremia (≥ 146mmol/L), plasma ADH levels, adverse events, and patients who changed fluids during study (reason)

  29. Results • 3/2008 – 12/2009 • 728 patients screened • 427 eligible • 258 were enrolled • 128 randomized to isotonic fluid • 130 randomized to hypotonic fluid • 4 patents from each group withdrew during study • 32 patients lacked data 14 lacked data 18 lacked data

  30. Baseline characteristics • between groups is similar • 77 of 258 (29.8%) admitted • to ICU postoperatively • No differences in baseline • sodium or fluid intake • Only 16 (6%) had pre-op • sodium levels ordered • Median time to starting fluid • intervention was 22minutes • post operatively (6hrs max) • Most common surgery: • Orthopedic, General, Urologic

  31. Results: Primary Outcome • Primary Outcomes: Risk of hyponatremia was higher in the hypotonic fluid group:

  32. Results: Secondary Outcomes • Plasma ADH levels on POD#1 elevated in both groups, but no difference (P= .208) • Subgroup analysis showed PICU patients at NO higher risk after adjusting for fluid type (P= .105) • 15 pts changed to open-label isotonic fluids • 12 (9.2%) vs.. 3 (2.3%); P = .036 (Hypotonic) (Isotonic) • with ‘Hyponatremia’ most common cited reason • 1 (0.8%) vs.. 7(5.4%); P = .033 (Hypotonic) (Isotonic)

  33. Study Limitations • Well-designed, blinded, randomized trial • May Not Generalize: Did not include patients requiring emergency surgeries; did not include non-surgical patients • Baseline Comparison Data: Most patients in study did not have ‘baseline’ lab values prior to enrollment • Missing Data: Not all patients included in study had all planned samples drawn.

  34. Clinical Bottom Line • Risk of hyponatremia is significantly higher in post-op patients receiving hypotonic fluids • Relative risk reduction of 44% with isotonic fluid • NNT to prevent 1 case of hyponatremia = 6 • Isotonic fluid use does not appear to increase adverse events or lead to hypernatremia • Current standard of post-operative fluid management should be re-evaluated… • Isotonic fluid may be safer!

  35. Failure to Thrive

  36. Background • Failure to Thrive (FTT) is common • As many as 10% of general pediatric patients • Outpatient management of failure to thrive “is fraught with difficulties because trying to organize a cohesive approach… is logistically challenging.” • Often assumed that admission may be the more efficient approach, with goal of coordinating multiple resources needed to diagnose and treat • FTT: Up to 5% of all admissions for children less than 2 years of age

  37. Background • Heavy resource utilization for these patients: • Labs, imaging, speech, nutrition, social work, and subspecialist consultation • Limited access to many of these resources during the weekend; even at large tertiary referral centers • Is the weekend the best time to admit these patients to the hospital?

  38. Study Objectives • To evaluate whether weekend admission of Failure to Thrive: • Affects the length of stay (LOS) • Affects the overall cost of the admission

  39. Methods • PHIS database • Administrative data from 43 free-standing children’s hospitals • Inclusion Criteria: • 2003-2011 (9 years of data) • All Children <2 years with primary admit diagnosis of Failure to Thrive • Data: Demographics, LOS, day of admit, diagnoses, procedures, tests, charges/costs

  40. Results • 23,332 patients met inclusion criteria • Median age: 7.5 months • 43.8 % (10,222) less than 6 months of age • Weekend admissions STAYED LONGER • LOS increased by 1.93 days (IRR: 1.20 [95% CI 1.18-1.22] • Weekend admissions COST MORE • Mean cost increase of $2785 per admission

  41. FTT on Weekends: Cost More, Stay Longer

  42. Results

  43. Limitations: • PHIS database limitations • Used surrogate data to make assumptions about how ‘sick’ patients were • Institutional bias in financial reporting is possible

  44. Author Bottom Line • Acknowledging that some of the weekend admissions had medical issues requiring immediate inpatient attention… • If HALF of the weekend admissions over the study period were simply converted to Monday admissions: • total savings in health care dollars would be in excess of $500,000 per year • or > $3.5 Million over the study period

  45. Gastroesophageal Reflux

  46. Background • Diagnosis and management of GERD remains challenging for families and pediatricians • From 1999 to 2004, 7-fold increase in use of prescription medication in infants with GERD • Growing evidence that acid reducing medications are NO BETTER than placebo in treating symptoms of GERD • Growing concern regarding safety of these agents in both adults and children

  47. Mechanism for increased infection Risk? • Gastric Acid is a known non-selective barrier to infection • Most pathogens will not survive at pH < 4 (normal gastric acidity) • Suppression of acid production may allow bacterial colonization and overgrowth (including pathogenic organisms) • PPIs & H2 Blockers may also directly inhibit leukocyte activity; thereby blunt immune response

  48. Objectives & Methods • Review of literature • Evaluate potential serious adverse effects associated with acid-suppressing medications in the pediatric population • PubMed Search: English Language, 0-18 yrs • Limited to original placebo controlled studies OR studies with comparison to non-acid suppression which specifically evaluated adverse events as part of study

  49. Results • 14 studies met inclusion criteria • 6 NICU studies • 5 PICU studies • 3 Non-Critical Care Population Studies • Both H2 Blockers and PPIs represented • Associate adverse events primarily ‘infectious’ in nature

More Related